- Home
- FGEN vs PCLA Comparison
FGEN vs PCLA Comparison
Compare FGEN & PCLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- PCLA
- Stock Information
- Founded
- FGEN 1993
- PCLA 2008
- Country
- FGEN United States
- PCLA Japan
- Employees
- FGEN N/A
- PCLA N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- PCLA Building Products
- Sector
- FGEN Health Care
- PCLA Consumer Discretionary
- Exchange
- FGEN Nasdaq
- PCLA Nasdaq
- Market Cap
- FGEN 33.5M
- PCLA 71.3M
- IPO Year
- FGEN 2014
- PCLA 2025
- Fundamental
- Price
- FGEN $7.12
- PCLA $0.50
- Analyst Decision
- FGEN Strong Buy
- PCLA
- Analyst Count
- FGEN 1
- PCLA 0
- Target Price
- FGEN $250.00
- PCLA N/A
- AVG Volume (30 Days)
- FGEN 42.5K
- PCLA 4.0M
- Earning Date
- FGEN 08-05-2025
- PCLA 01-01-0001
- Dividend Yield
- FGEN N/A
- PCLA N/A
- EPS Growth
- FGEN N/A
- PCLA N/A
- EPS
- FGEN N/A
- PCLA N/A
- Revenue
- FGEN $6,996,000.00
- PCLA $5,475,228.00
- Revenue This Year
- FGEN N/A
- PCLA N/A
- Revenue Next Year
- FGEN N/A
- PCLA N/A
- P/E Ratio
- FGEN N/A
- PCLA N/A
- Revenue Growth
- FGEN N/A
- PCLA 40.19
- 52 Week Low
- FGEN $4.50
- PCLA $0.37
- 52 Week High
- FGEN $30.50
- PCLA $9.80
- Technical
- Relative Strength Index (RSI)
- FGEN 52.22
- PCLA N/A
- Support Level
- FGEN $7.04
- PCLA N/A
- Resistance Level
- FGEN $7.56
- PCLA N/A
- Average True Range (ATR)
- FGEN 0.57
- PCLA 0.00
- MACD
- FGEN 0.03
- PCLA 0.00
- Stochastic Oscillator
- FGEN 45.20
- PCLA 0.00
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
About PCLA PicoCELA Inc. American Depositary Shares
PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.